Home › Funds › Siren, L.L.C. › VNDA
Siren, L.L.C. position in VNDA
ADARx Pharmaceuticals, Inc. · Health Care
Siren, L.L.C. reported holding 1,925,794 shares of VNDA (ADARx Pharmaceuticals, Inc.) in its Q3 2026 13F filing — a position valued at US$38.4M, representing 0.91% of its reported portfolio and ranking #31 among its reported holdings. Siren, L.L.C. first reported this position in Q3 2026.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Siren, L.L.C.'s VNDA position evolved
Siren, L.L.C. first disclosed a stake in VNDA in Q3 2026 at 1,925,794 shares (US$38.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 1.93M | $38.40M | New |
About VNDA and 13F data
VNDA (ADARx Pharmaceuticals, Inc.) is a Health Care company. 27 other funds we track also report a position in VNDA — the largest reported positions include AIGH Capital Management LLC (US$12.5M), Krensavage Asset Management, LLC (US$7.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VNDA
- AIGH Capital Management LLC 2.04M sh · $12.51M · Q2 2026
- Krensavage Asset Management, LLC 1.18M sh · $7.22M · Q2 2026
More on Siren, L.L.C.
FAQ
How long has Siren, L.L.C. held VNDA?
Siren, L.L.C. has disclosed VNDA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Siren, L.L.C.'s current position in VNDA?
As of Q3 2026, Siren, L.L.C. holds 1.93M shares of VNDA (ADARx Pharmaceuticals, Inc.), valued at $38.40M, representing 0.91% of its reported portfolio and ranking #31.
Has Siren, L.L.C. been buying or selling VNDA?
In the latest 13F filing (Q3 2026), Siren, L.L.C. newly opened its position in VNDA.
Which other funds hold VNDA?
Other major institutional holders of VNDA include AIGH Capital Management LLC, Krensavage Asset Management, LLC, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.